Drug General Information |
Drug ID |
D08UWZ
|
Former ID |
DNC010722
|
Drug Name |
BMS-687453
|
Drug Type |
Small molecular drug
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C22H21ClN2O6
|
Canonical SMILES |
CC1=C(N=C(O1)C2=CC=C(C=C2)Cl)COC3=CC=CC(=C3)CN(CC(=O)O)<br />C(=O)OC
|
InChI |
1S/C22H21ClN2O6/c1-14-19(24-21(31-14)16-6-8-17(23)9-7-16)13-30-18-5-3-4-15(10-18)11-25(12-20(26)27)22(28)29-2/h3-10H,11-13H2,1-2H3,(H,26,27)
|
InChIKey |
UJIBXDMNCMEJAY-UHFFFAOYSA-N
|
PubChem Compound ID |
|
Target and Pathway |
Target(s) |
Peroxisome proliferator activated receptor alpha |
Target Info |
Inhibitor |
[1]
|
KEGG Pathway
|
PPAR signaling pathway
|
cAMP signaling pathway
|
Adipocytokine signaling pathway
|
Glucagon signaling pathway
|
Non-alcoholic fatty liver disease (NAFLD)
|
Hepatitis C
|
Pathway Interaction Database
|
RXR and RAR heterodimerization with other nuclear receptor
|
Reactome
|
RORA activates gene expression
|
BMAL1:CLOCK,NPAS2 activates circadian gene expression
|
PPARA activates gene expression
|
YAP1- and WWTR1 (TAZ)-stimulated gene expression
|
Transcriptional activation of mitochondrial biogenesis
|
Activation of gene expression by SREBF (SREBP)
|
Transcriptional regulation of white adipocyte differentiation
|
Nuclear Receptor transcription pathway
|
Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
|
Circadian Clock
|
WikiPathways
|
Nuclear Receptors in Lipid Metabolism and Toxicity
|
Nuclear Receptors Meta-Pathway
|
Estrogen Receptor Pathway
|
PPAR Alpha Pathway
|
Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
|
Transcriptional Regulation of White Adipocyte Differentiation
|
YAP1- and WWTR1 (TAZ)-stimulated gene expression
|
Activation of Gene Expression by SREBP (SREBF)
|
Adipogenesis
|
SREBF and miR33 in cholesterol and lipid homeostasis
|
Circadian Clock
|
Nuclear Receptors
|
References |
REF 1 | J Med Chem. 2010 Apr 8;53(7):2854-64.Discovery of an oxybenzylglycine based peroxisome proliferator activated receptor alpha selective agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid (BMS-687453). |